Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature. (2023)

First Author: Andrews A
Attributed to:  Child Growth and development funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvad039

PubMed Identifier: 36943306

Publication URI: http://europepmc.org/abstract/MED/36943306

Type: Journal Article/Review

Volume: 188

Parent Publication: European journal of endocrinology

Issue: 4

ISSN: 0804-4643